175278-07-6 Usage
General Description
2-(Trifluoromethoxy)benzyl alcohol is a chemical compound with the molecular formula C8H7F3O2. It is a benzyl alcohol derivative with a trifluoromethoxy group attached to the benzene ring. 2-(Trifluoromethoxy)benzyl alcohol is commonly used as a building block in organic synthesis, and it has been studied for its potential pharmacological properties. It is also used as a reagent in chemical reactions, particularly in the synthesis of pharmaceuticals and agrochemicals. 2-(Trifluoromethoxy)benzyl alcohol is a colorless liquid with a slightly sweet odor, and it is considered to be relatively stable under normal conditions. However, it should be handled with care as it can cause irritation to the skin, eyes, and respiratory system.
Check Digit Verification of cas no
The CAS Registry Mumber 175278-07-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,5,2,7 and 8 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 175278-07:
(8*1)+(7*7)+(6*5)+(5*2)+(4*7)+(3*8)+(2*0)+(1*7)=156
156 % 10 = 6
So 175278-07-6 is a valid CAS Registry Number.
InChI:InChI=1/C8H7F3O2/c9-8(10,11)13-7-4-2-1-3-6(7)5-12/h1-4,12H,5H2
175278-07-6Relevant articles and documents
RORγ MODULATORS
-
Page/Page column 21; 38; 66, (2018/04/13)
The invention provides an RORγ receptor agonist comprising a compound of formula (I), wherein the variables are as defined herein. These compounds are analogous to known RORγ receptor antagonists. The invention further provides a method of activating -the nuclear receptor RORγ, comprising -contacting the RORγ with an effective amount or concentration of a compound of the invention; and a method of treating cancer in a patient, comprising administering to the patient an effective dose of a compound of the invention.
Tocolytic oxytocin receptor antagonists
-
, (2008/06/13)
This invention relates to certain novel benzoxazinone compounds and derivatives thereof, their synthesis, and their use as oxytocin receptor antagonists. One application of these compounds is in the treatment of preterm labor in mammals, especially humans. The ability of the compounds to relax uterine contractions in mammals also makes them useful for treating dysmenorrhea and stopping labor prior to cesarean delivery.